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Abstract  16 
From observational studies, farmers who use parenteral antibacterials to promptly treat all sheep 17 
with footrot (FR) or interdigital dermatitis (ID) have a prevalence of lameness of <2% compared 18 
with a prevalence of 10% lameness reported by farmers who treat  lame sheep bytrimming 19 
affected feet. We tested the hypothesis that prompt treatment of sheep lame with naturally 20 
developing FR or ID with parenteral and topical antibacterials reduces the prevalence and 21 
incidence of lameness with these conditions compared with less frequent treatment by trimming 22 
hoof horn and applying topical antibacterials. A further hypothesis was that reduction of ID and 23 
FR would improve productivity. A lowland sheep flock with 700 ewes was used to test these 24 
hypotheses in an 18-month within farm clinical trial with four groups of ewes: two intervention 25 
and two control. The duration and severity of lameness was used to categorise sheep into three 26 
weighted scores of lameness (WLS): never lame (WLS0), lame for a maximum of six days with 27 
locomotion score 2 (WLS1) and lame for more than six days or a higher locomotion score 28 
(WLS2). The intervention reduced the prevalence of lameness due to FR and ID in ewes and 29 
lambs and the incidence of lameness in ewes. The WLS was significantly lower in sheep in the 30 
intervention groups. Ewes with a higher WLS were subsequently significantly more likely to 31 
have a body condition score (BCS) <2.5 and have lame lambs. Significantly more ewes lambed 32 
and successfully reared more lambs that were ready for slaughter at a younger age in the 33 
intervention versus control groups. There was an increase in the gross margin of £630 / 100 ewes 34 
mated in the intervention group, including the cost of treatment of £150 / 100 ewes mated. We 35 
conclude that prompt parenteral and topical antibacterial treatment of sheep lame with ID and FR 36 
reduced the prevalence and incidence of these infectious conditions and led to improved health, 37 
welfare and productivity.  38 
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 42 
1. Introduction  43 
Lameness is one of the greatest concerns for poor welfare in sheep (Goddard et al., 2006; 44 
Fitzpatrick et al., 2006). It has been estimated to cost the UK industry £24 million / annum 45 
(Nieuwhof and Bishop, 2005). More than 90% of farmers in the UK report lameness in their 46 
sheep, with a farmer-estimated prevalence of 10% with more than 80% of lameness caused by 47 
footrot (FR) and interdigital dermatitis (ID) (Grogono-Thomas and Johnston, 1997; Kaler and 48 
Green, 2008a). In a study of 209 sheep farmers, those treating all sheep with FR with parenteral 49 
antibacterials and foot sprays reported a significantly lower peak prevalence of FR of 2% 50 
compared with the 9%reported by farmers who treated FR by paring the hoof horn and spraying 51 
disinfectant on to the foot (Wassink et al., 2003). In addition, farmers who reported prompt 52 
treatment of mildly lame sheep also reported a lower prevalence of lameness than those treating 53 
groups of lame sheep (Kaler and Green, 2008). Further evidence for the benefits of parenteral 54 
antibiotics comes from a prospective longitudinal study of 160 sheep on one farm where the 55 
treatment of sheep with FR and ID with parenteral and topical antibacterials was associated with 56 
a lower incidence of lameness in the subsequent 4 weeks (Green et al., 2007).  57 
Dichelobacter nodosus is the necessary pathogen to cause FR (Beveridge, 1941) and is present in 58 
the majority of cases of both ID (inflammation of the interdigital skin) and FR (separation of 59 
hoof horn from the underlying tissue) (Moore et al., 2005). As a consequence, ID and FR are 60 
often a continuum of the same disease. The terms that are equivalent to ID and FR in Australia 61 
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are benign and virulent FR (Depiazzi et al., 1991). D. nodosus is an anaerobic bacterium that has 62 
no known resistance to antibacterials. Parenteral antibacterial treatment of FR leads to recovery 63 
from lesions in over 90% of sheep (Sterk, 1960; Egerton et al., 1968; Grogono-Thomas et al., 64 
1994) and in a recent factorial design study, over 90% of sheep with FR treated with long acting 65 
oxytetracycline recovered from lesions and lameness within 10 days whilst <30% sheep treated 66 
with foot trimming recovered in this time period (Kaler et al., 2010). This, together with the 67 
evidence above and biological reasoning, led to the hypothesis that prompt treatment of lame 68 
sheep with ID or FR with parenteral and topical antibacterials would reduce the prevalence 69 
(because of a reduced duration of lameness) and incidence (because a reduced infectious period 70 
would decrease the probability of transmission of D. nodosus between sheep) of lameness caused 71 
by these diseases compared with the traditional treatment of trimming hoof horn and applying a 72 
topical bactericide. Consequently, the health, welfare and productivity of the flock should 73 
increase. To test these hypotheses, a within flock clinical trial comparing these two treatments 74 
was set up on a convenience-selected farm in Oxfordshire with a commercial lowland spring-75 
lambing flock of approximately 700, mainly North Country mule ewes. The objective was to 76 
compare prompt treatment of FR and ID with parenteral and topical antibacterial with a typical 77 
farmer’s management of FR and ID (Wassink et al., 2003; 2004) which includes less frequent 78 
treatment of lame sheep with ID and FR by trimming hoof horn and applying a topical 79 
bactericide. The study lasted from March 2005 to December 2006.  80 
 81 
2. Materials and Methods 82 
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2.1 Study design March to September 2005 83 
A sample size calculation was used to estimate the number of ewes required per treatment to test 84 
a reduction in lameness of 50% assuming a prevalence of lameness of 10%, 80% power and 95% 85 
significance. A total of 147 ewes were required per treatment.  86 
Ewes lambed from the second week of March 2005. Ewes and lambs were identified with both 87 
ear tags and flank markings. The age (dentition), body condition score (BCS) (MAFF, 1994) and 88 
conformation of feet of ewes were recorded. All foot lesions were also (www.footrotinsheep.org) 89 
recorded. Ewes with triplets were excluded from the trial. After the ewes lambed they were 90 
allocated by researchers to one of two fields with similar pasture type and stocking density using 91 
stratified random sampling on age, BCS, foot conformation and presence of existing footrot 92 
lesions. Once the first two matched fields were stocked, two further fields with similar pasture 93 
type were filled. Each group consisted of approximately 175 ewes and their lambs (Table 1). The 94 
matched groups were moved between fields simultaneously and to similar pasture types and 95 
stocking densities throughout the trial period. In May 2005, when the youngest lamb in each 96 
group was four weeks old, one group from each pasture type was selected to be an intervention 97 
treatment group by tossing a coin; the other became the matched control group, thus giving two 98 
intervention and two control groups. Six observers collected data on age, BCS, locomotion and 99 
foot lesions over the 18-month study. All observers were trained by GJW who attended one day 100 
of data collection each week to check that observers remained consistent in their scoring.  101 
A locomotion scoring system (Kaler et al., 2008b) was used by these trained researchers to score 102 
the locomotion of all sheep in all four groups each day for 5 weeks and then each weekday until 103 
October 2005. The identity, locomotion score and the limb or limbs that were observed lame 104 
were recorded for every sheep that had a locomotion score ≥1 in each group.  105 
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Treatments 106 
Intervention groups: In the intervention groups, sheep with a locomotion score ≥2 were caught 107 
for diagnosis and treatment within 1-3 days of becoming lame. Their feet were inspected and the 108 
type and severity of lameness recorded. Sheep with FR or ID were treated with parenteral 109 
antibacterials (Terramycin LA 200 mg/ml, Pfizer Ltd; 20mg per kg bodyweight for ewes; and 110 
Engemycin LA 200 mg/ml, Intervet/Schering-Plough Animal Health; 15mg per kg bodyweight 111 
for lambs) and an antibacterial spray (Terramycin Aerosol Spray, 150ml pack, 4g 112 
Oxytetracycline Hydrochloride 3.92% w/w, Pfizer Ltd.). Other foot lesions were treated using 113 
standard protocols (Winter, 2004). When a sheep in an intervention group had a locomotion 114 
score ≥2 ten days after treatment it was re-caught, re-examined and re-treated.  115 
Control groups: Lame sheep in the control groups were treated by the farm shepherd who had 116 
managed the flock for over 10 years. He inspected each group of sheep as part of his usual 117 
routine and was blind to the locomotion scores. When he elected to treat a sheep he was assisted 118 
by the research team who recorded the foot affected and cause of lameness. If ID was present, 119 
the shepherd trimmed the hoof horn wall and sprayed the feet with the topical spray above. If FR 120 
was present the hoof horn over lesions was trimmed away and the exposed lesions were sprayed 121 
with the topical spray. Other foot lesions were treated using standard protocols (Winter, 2004).  122 
 123 
2.2 Changes to the study design after September 2005 124 
Lambs were weaned on 20/08/2005. One month after weaning, one intervention group was 125 
selected by tossing a coin (solid grey line, Figure 1) and swapped with its matched control group 126 
in a cross over design. As a result, approximately 25% of the sheep were always in an 127 
intervention and 25% always in a control group, with the other 50% crossing over. Some ewes 128 
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(Table 1) were culled from all four groups and replacement ewes were added to the groups to 129 
balance the number of sheep per group. Both replacement ewes and rams used for mating were 130 
examined and if necessary treated. These sheep were not put with their group until sound. From 131 
October 2005, the treatments above were carried out twice each week in the intervention group 132 
rather than every week-day. No lame sheep were treated during early pregnancy (between 24
th
 of 133 
October 2005 and the 9
th
 of January 2006) except when sheep were gathered on 8
th
 and 18
th
 134 
November and 12
th
 December. The intervention groups were combined to facilitate housing on 135 
the 10
th
 of February 2006. The control groups were also combined. Ewes were housed in several 136 
large straw-bedded solid-floored pens until they lambed. Straw was added to the pens each day 137 
and was 30 – 40 cm deep. Ewes were moved to individual pens after they had lambed. 138 
 139 
2.3 Study design from May to September 2006 140 
Two intervention groups and two control groups were re-formed from the merged intervention 141 
group and merged control group, respectively (Table 2). No ewes were put out to pasture until 142 
sound. Treatments for lameness started when the youngest lamb in a group was four weeks old. 143 
The intervention and control groups were treated as for the first lamb production season (2005) 144 
with the exception that lambs with ID were treated with topical antibacterials but not parenteral 145 
antibacterials.  146 
 147 
2.4 Monitoring health and production in the flock 148 
Ewe age, BCS and foot conformation and foot lesions were scored again at weaning in 2005 and 149 
at lambing and weaning 2006. The number of lambs born alive and dead, and the sex, birth 150 
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weight and adoption details of all lambs were recorded in 2005 and 2006. Ewe and lamb deaths 151 
and the date lambs left the farms as finished or store lambs were also recorded in 2005 and 2006. 152 
 153 
2.5 Data storage and analysis 154 
Data were entered into a database (Access 2003, Microsoft) and checked for errors before 155 
statistical analysis in Stata SE 10, (Statacorp) and MLwiN 2.0 (Rasbash et al., 1999). Ewe body 156 
condition was categorised into below recommended (<2.5) and at or above recommended (≥2.5), 157 
birth weights were categorised by a good vs less good birth weight of <5.5kg and ≥ 5.5 kg and 158 
ewe age at a median of  <4 years and ≥ 4 years. Breed was categorised into mule and other cross-159 
breeds. Parametric and non-parametric tests were used to investigate univariable associations as 160 
appropriate for the data distributions.  161 
Ewes at pasture with lambs from May – August 2005 and May – September 2006 were analysed 162 
separately from weaned ewes were at pasture; September 2005 to housing in February 2006. 163 
Data during housing were not used in the analysis because deep litter straw restricted observation 164 
of the ewes’ legs. 165 
The groups compared were intervention and control groups in 2005 and 2006 and also the sub 166 
group of ewes that were always in an intervention group or always in a control group (n = 176). 167 
These ewes were dispersed within the two intervention and two control groups in 2006.  168 
 169 
The mean prevalence and incidence of lameness were plotted to visualise the effects of the 170 
intervention and the cross-over design. The prevalence and incidence of lameness in matched 171 
groups were compared using t tests. The prevalence was calculated from the number of sheep 172 
with locomotion score 2 or above at an observation divided by the number of sheep in the group 173 
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divided by the number of days that observations occurred in a period. The incidence was 174 
calculated in the same way except that the denominator was the group size minus the number of 175 
non-susceptible sheep (those lame within the last 10 days). 176 
Sheep had up to four episodes of lameness in a time period. To test the hypothesis that duration 177 
and severity of lameness affected production an weighted lameness score (WLS) was calculated 178 
where d = duration of an episode of lameness, m = maximum locomotion score during the 179 
episode of lameness, Σ = summed for all episodes of lameness in a time period 180 
WLS = Σ (d*m)  181 
an episode of lameness started on the day the locomotion score was first observed ≥2 and ended 182 
on the day midway between the last observation of locomotion score ≥2 and next observation of 183 
locomotion score <2, unless a sheep was observed lame again within 10 days in which case this 184 
was part of the current episode.   185 
The WLS was then categorised into WLS0, sheep that never had a locomotion score ≥2, WLS1, 186 
sheep with a weighted lameness score ≤12 (e.g. a sheep lame over 2 episodes, one with 3 days of 187 
locomotion score 2 and another with 2 days of locomotion score 3) and WLS2, sheep with a 188 
weighted lameness score >12. This three level categorical variable was used in an ordinal 189 
multilevel multinomial regression analysis (Goldstein, 2003) to investigate impact of treatment 190 
on duration and severity of lameness. A multilevel binomial logistic regression analysis was used 191 
to investigate factors associated with ewe body condition (<2.5 or ≥2.5). Cox proportional 192 
survival analysis with robust estimates of variance using the cluster-option in Stata (Williams, 193 
2000) was used to investigate the age at finishing for lambs. 194 
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A cost-benefit analysis of the intervention treatment vs control treatment was done using 195 
production figures from sheep that were in the intervention or control groups for the whole 18-196 
month trial period and other existing data.  197 
 198 
3. Results  199 
3.1 Prevalence and incidence of lameness in ewes and lambs 200 
Descriptive statistics are presented in Tables 1 and 2. The four groups started with similar 201 
numbers of ewes by BCS, foot conformation, FR and ID. Although there were fewer treatments 202 
in the control groups (Tables 1 and 2) there were significantly more episodes of lameness with a 203 
maximum locomotion score >2 compared with the intervention groups in both ewes and lambs 204 
(Tables 3 and 4) over the trial period. Ewes and lambs in the intervention groups were lame for 205 
significantly fewer days for each episode of lameness: 4.3 (CI: 4.0 – 4.6) and 4.0 (CI: 3.6 – 4.3) 206 
compared with ewes and lambs in the control groups 7.9 (CI: 7.2 – 8.7) and 7.3 (CI: 6.4 – 8.2) 207 
respectively.  208 
The prevalence and incidence of lameness in ewes in the intervention groups fell in the first 4 – 8 209 
weeks each time the intervention was introduced in 2005 and in 2006 (Figure 1). The mean 210 
prevalence and incidence of lameness in ewes was significantly lower in intervention vs control 211 
groups the both production seasons (Tables 1 and 2). In 2005, the mean prevalence of lameness 212 
in lambs was significantly lower in the intervention groups compared with the control groups 213 
from week 8 onwards (Figure 2, Table 1) but there was no significant difference in the mean 214 
incidence of lameness.  215 
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Over the intervention period, 35 isolates of D. nodosus cultured from ewes treated with 216 
parenteral antibacterials at least twice were tested for antibacterial resistance to oxytetracycline 217 
using a modified MIC test. All isolates were sensitive to oxytetracycline (DEFRA, 2008). 218 
 219 
3.2 Factors associated with lameness  220 
The intervention treatment significantly reduced the number and / or severity of lameness events: 221 
ewes and lambs in the control groups were more likely to have a WLS2 than ewes and lambs in 222 
the intervention groups (Table 1). WLS2 was also more likely in ewes > 4 yrs old (Table 5) and 223 
in lambs which were single born, male or their mother was lame, especially if the ewe had had a 224 
WLS2 (Table 5). Ewes were less likely to become lame between September 2005 and housing in 225 
February 2006 if they had been in the intervention group in 2005. A ewe was significantly more 226 
likely to become lame in this period if she had been lame in the previous lamb production period 227 
(Table 1).  228 
 229 
3.3 Factors associated with ewe body condition  230 
At the start of the intervention there were 73% sheep in the intervention and 77% sheep in 231 
control groups with BCS ≥2.5 (P>0.05). There were significantly more ewes with a BCS ≥2.5 in 232 
the intervention groups at weaning 2005 (62%), 2006 (76%) and lambing 2006 (83%) compared 233 
with ewes on the control groups with 26%, 62% and 61% with BCS ≥2.5 respectively at these 234 
times (P<0.01). BCS ≥2.5 at weaning 2005 was associated with a previous WLS of 0 or 1 than 235 
WLS2, a BCS ≥2.5 at lambing 2005, rearing one lamb, less than 4 years of age and mule breed 236 
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(Table 7). Ewes with a BCS≥ 2.5 at lambing 2006 were more likely to have had a WLS 0 or 1 237 
than WLS2 in 2005, a BCS ≥ 2.5 at weaning 2005 and produced a single lamb in 2006. 238 
 239 
3.4 Cost-benefit analysis of the intervention 240 
The cost of reducing the prevalence of lameness in the first six weeks of the study in 2005 was 241 
£45 and £278 per 100 ewes in the two intervention groups; the prevalence of lameness fell more 242 
rapidly in one intervention group than the other (Figure 1). 243 
There were 167 ewes that were either in intervention or control groups for the whole project. 244 
From week 8 until the end of the project the mean prevalence and incidence of lameness in ewes 245 
that were always in intervention groups (solid black line, Figure 1) were significantly lower than 246 
in ewes that were always in control groups (dashed black line, Figure 1) (2.4 (95% CI: 1.7 – 3.1) 247 
vs. 5.6 (CI: 4.6 – 6.6) and 1.4 (CI: 1.0 – 1.8) vs. 2.5 (CI: 1.9 – 3.1), respectively). These ewes 248 
were used to estimate the impact of the intervention on productivity because they remained under 249 
the same treatment for two seasons.  250 
There were fewer barren ewes and ewes that died among ewes always in the intervention group 251 
than always in the control group, resulting in more productive ewes per 100 ewes put to the ram 252 
and lower replacement costs (Table 9). There were 17 more lambs reared per 100 ewes put to the 253 
ram. In 2006, one year after the intervention was started, a significantly higher percentage of 254 
lambs born to ewes always in the intervention group were finished before weaning compared 255 
with lambs born to ewes in the control group; 18% versus 6%, respectively (Table 8). 256 
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The additional cost of the intervention was calculated as £150 per 100 ewes put to the ram (Table 257 
4). The intervention improved the gross margin by £630 in 2006 (Table 9), more than 50% 258 
higher than the gross margin in the control group. 259 
 260 
4. Discussion  261 
4.1 Impact on prevalence and incidence of footrot and interdigital dermatitis 262 
We have demonstrated that prompt treatment of individual lame sheep with parenteral and 263 
topical antibacterials given to those with FR or ID significantly reduced the prevalence and 264 
incidence of lameness in ewes compared with delayed treatment of individual lame ewes with 265 
FR/ID treated with foot trimming and topical antibacterials. This latter management is used by 266 
the majority of sheep farmers in the UK and elsewhere in the world and so was an ideal control 267 
to provide useful results to farmers and to compare with a new practice. It is clear from our 268 
results that prompt treatment of FR/ID with parenteral and topical antibacterials was not only 269 
beneficial to sheep health and welfare but also cost effective, in that the ewes in the intervention 270 
groups were in better body condition, produced more lambs and reared them more rapidly, 271 
presumably because of their better body condition.  272 
The reduction in prevalence of lameness occurred in ewes and lambs on each occasion that the 273 
intervention was started (May 2005, September 2005, May 2006). The reduction in incidence of 274 
lameness suggests that the treatment reduced re-occurrence in the same sheep; this could suggest 275 
that transmission of D. nodosus was reduced or foot health was improved. This might explain 276 
why there was no reduction in incidence of FR or ID in lambs; very few lambs were treated more 277 
than once. Alternatively, it might have been lack of power in the study because few lambs were 278 
lame.   279 
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All ewes with ID (as well as those with FR) were treated with parenteral antibacterials because in 280 
Moore et al., (2005) ID lesions were infected with D. nodosus, the cause of footrot on 60% of 281 
occasions. Lambs with ID were treated with parenteral antibiotics in 2005 but not 2006 because 282 
the farm shepherd was concerned about meat withdrawal times.  283 
 284 
4.2 Impact on productivity 285 
The impact of footrot lesions on bodyweight, lamb growth rates and wool growth in untreated 286 
sheep has been reported previously (Stewart et al., 1984; Marshall et al., 1991; Nieuwhof et al., 287 
2008). This is the first paper to report the impact of duration and severity of lameness on 288 
production in meat sheep. It is useful to know that treating sheep lame with FR or ID promptly 289 
will make them more productive. The reduction in severity and duration of lameness in 290 
intervention groups was statistically associated with a higher body condition score (BCS) and 291 
greater lamb production. This is probably because low BCS affects fertility and fecundity (Rhind 292 
and McNeilly, 1986; Forcada et al., 1992; Abecia et al., 2006). Low BC in ewes also leads to 293 
high mortality in lambs (Binns et al., 2002), probably because of low birth weights (Christley et 294 
al., 2003; Everett-Hincks and Dodds, 2008) and insufficient production of colostrum and milk 295 
(Mellor and Murray, 1985; O’Doherty et al., 1997).  296 
Significantly more lambs were finished before weaning in the intervention groups than in the 297 
control groups. This is a very important component of the cost effectiveness of the treatment 298 
because one of the main factors determining profitability of lowland flocks is the percentage of 299 
lambs finished (MLC, 2001). This is because supplementary feed to lambs after weaning is 300 
expensive and so impacts on profits. This, together with the production benefits from the current 301 
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intervention (Table 4), indicates that it was cost effective to put in the extra time (approximately 302 
two treatments per 100 ewes per week) and drug resources needed to treat individual lame sheep.  303 
Rapid treatment of lame sheep might also prevent hyperalgesia that is reported in chronically 304 
lame sheep (Fitzpatrick et al., 2006) and so ensure that energy is put into body condition, 305 
reproduction and milk production.  306 
 307 
4.3 Concerns regarding the development of antibiotic resistance 308 
In this trial there was no evidence that the parenteral treatments led to bacterial selection for 309 
resistance to oxytetracycline. This might be because although there were many treatments they 310 
were staggered over time with 1 – 8 treatments per group per week, so there was no selective 311 
pressure for development of resistance. Whilst the use of parenteral antibiotic to treat infectious 312 
lameness might not be considered the ideal, it is highly efficacious as a treatment and, as this 313 
trial has clearly shown, of considerable benefit to animal welfare and production. It is the best 314 
current treatments, the alternatives, trimming and spraying individuals and the whole flock 315 
methods of footbathing and footrot vaccination are less effective treatments and in many sheep 316 
flocks in the UK do not lead to acceptable levels of lameness control (Kaler and Green, 2009; 317 
Kaler et al., 2010; Schwartzkoff et al., 1993). 318 
 319 
4.4 Study design 320 
This within farm clinical trial testing two treatments was carried out on one lowland spring-321 
lambing flock with a compliant farm management team. This approach enabled us to make 322 
detailed observations and collect a comprehensive, reliable dataset. We are uncertain whether the 323 
improvements that occurred through the intervention would be quantitatively similar on other 324 
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lowland sheep farms with similar management and prevalence of FR and ID in the UK and 325 
worldwide, but we would expect the qualitative results to be generalisable. The distribution of 326 
age, BCS, foot conformation (Hawker, 2007) and prevalence of lameness in ewes at the start of 327 
the study were similar in all four groups, suggesting that the random stratification was successful. 328 
The prevalence of lameness (8%) was also similar to that reported by farmers in previous studies 329 
(Grogono-Thomas and Johnson, 1997; Wassink et al., 2003; Kaler and Green, 2009). The group 330 
of ewes that moved from intervention to control came from the intervention group with the most 331 
rapid reduction in lameness in 2005 (grey solid bar Figure 1). The cross over in 2006 was used to 332 
demonstrate that lameness patterns followed the treatment regimes. The incidence and 333 
prevalence of lameness rose when sheep were moved from intervention to control groups and 334 
vice versa. This suggests that lameness was a correlate for control of FR and ID. The time to a 335 
stable prevalence of lameness of 1 – 2%, and the number of treatments required varied between 336 
intervention groups. This might have occurred because of differences in the environment in the 337 
fields within treatments or that some sheep in intervention group 2 were more infectious. 338 
Treatments were matched by field type to minimise the potential impact of climate and soil. 339 
Sheep were not in sufficient numbers of fields to test a treatment field interaction. Climate is 340 
important in clinical impact of D. nodosus (Green and George, 2008) and is one explanation for 341 
the difference in incidence of lameness between 2005 (a very wet, cool year) and 2006 (a hot, 342 
dry year). We used groups with the same treatments rather than individuals within groups 343 
because we wanted to test whether the treatment of lame sheep reduced transmission between 344 
sheep.  345 
To minimise observer bias, all observers (n=6) were trained by GJW who also observed the 346 
observers once each week to prevent drift in scoring of sheep. In addition, observers regularly 347 
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discussed scores to confirm continued agreement. A validated locomotion scoring system (Kaler 348 
and Green, 2008b) was used to assess the quantity and severity of lameness with paired groups 349 
inspected on the same day. The scales for scoring ID, FR lesions and foot integrity have not yet 350 
been evaluated and consequently might introduce error. Every effort was made to ensure that all 351 
sheep in each field were observed at each observation. Sheep were marked on their flank and had 352 
large ear tags. Despite this, sheep that were being observed after a lameness event were 353 
occasionally missed for one observation. There were no further feasible improvements that could 354 
be made to the design to reduce these reporting errors.  355 
The farmer was blind to locomotion scores to prevent the possibility of him altering his usual 356 
management. He was an experienced stock person who had managed the flock for over 10 years 357 
and his treatment of FR is typical of that used by many farmers in GB (Wassink et al., 2003, 358 
2004; Kaler and Green, 2008, 2009). This makes the results from this study highly relevant to 359 
many farmers and was the ideal baseline control for this clinical trial. It does mean that this study 360 
does not compare a treatment alone but time to known good treatment. There is a wealth of 361 
evidence that antibacterials lead to recovery from FR (Sterk, 1960; Egerton et al., 1968; 362 
Grogono-Thomas et al., 1994; kaler et al., 2010) and the aim of this study was more than 363 
repeating such research. Our results highlight that it is the duration and severity of lameness that 364 
affects sheep health and productivity and that is why we see an improved performance in sheep 365 
in the intervention groups. Rate of treatment is essential as well as appropriate treatment. 366 
 367 
5. Conclusions  368 
We conclude that prompt individual treatment of all lame sheep with ID and FR with parenteral 369 
and topical antibacterials reduced the prevalence of FR and ID in ewes and lambs and the 370 
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incidence of these conditions in ewes. The reduced duration and severity of lameness improved 371 
the production of the flock through increased body condition in ewes which led to higher 372 
lambing rates, fewer deaths in ewes and lambs and earlier finishing of lambs. The cost-benefit 373 
was an increase in gross margin of £630 (€932) per 100 ewes put to the ram.   374 
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Figure 1. Two-week mean prevalence and incidence of lameness in ewes between May 2005 472 
and September 2006 473 
Key: solid black line = always intervention, dashed black line = always control, solid grey line = 474 
intervention then intervention crossed over from control, dashed grey line = control then control 475 
crossed over from intervention 476 
Figure 2. Two-week mean prevalence and incidence of lameness in lambs over two lamb 477 
production seasons, May – August 2005 and May – August 2006 478 
Key: solid black line = dam always intervention, dashed black line = dam always control, solid 479 
grey line = dam intervention (2005) then intervention crossed over from control (2006), dashed 480 
grey line = dam control (2005) then control crossed over from intervention (2006) 481 
482 
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Table 1. Descriptive statistics 2005 483 
 484 
 
 
Intervention 
Group 1 
Intervention 
Group 2 
Control  
Group 1 
Control  
Group 2 
 Control yr 2  Intervention 
yr 2 
 
No. ewes 175 177 181 177 
No. lambs 364 323 357 312 
Date first ewe lambed 7/03/2005 17/03/2005 11/03/2005 17/03/2005 
% FR foot exam March 2005 26.1 20.5 19.4 20.9 
% ID foot exam March 2005 44.9 43.8 38.9 50.3 
No. treatments for FR & ID 78 232 20 18 
No. treatments other lameness 5 4 2 0 
Prevalence (95% CI)  
lame ewes 
1.9  
(1.1 – 2.6) 
1.1  
(0.6 – 1.7) 
4.6  
(2.6 – 6.7) 
5.3  
(3.5 – 7.1) 
Incidence (95% CI)  
lame ewes  
1.3  
(0.7 – 1.8) 
0.8  
(0.4 – 1.2) 
2.3  
(1.4 – 3.1) 
2.5  
(2.0 – 3.0) 
Prevalence (95% CI) 
lame lambs 
0.8 
(0.65 – 0.95) 
1.41  
(CI: 0.9 – 1.8) 
2.5  
(CI: 1.7 – 3.3) 
1.45 (1.2 – 
1.7) 
Incidence (95% CI)  
lame lambs  
0.4  
(CI: 0.2 – 0.6) 
1.1  
(0.8 – 1.4) 
1.1  
(CI: 0.8 – 1.4) 
0.6 
(0.4 – 0.8) 
No. (%) culled 2005  49 (28) 31 (18) 52 (29) 54 (36) 
% FR foot exam Sept. 2005 5 (3) 10 (6.1) 22 (13) 18 (11) 
% ID foot exam Sept. 2005 5 (3) 31 (19) 20 (12) 66 (39) 
No. number, % percent 485 
  486 
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Table 2. Descriptive statistics 2006 487 
 488 
 
 
Intervention 
Group 3 
Intervention 
group 4 
Control 
Group 3 
Control 
Group 4 
No. ewes 147 147 144 132 
No. lambs 265 278 267 240 
Date first ewe lambed 13/03/2005 22/03/2006 12/03/2006 20/03/2006 
No. (% )FR at exam March 2006 5 (3.4) 6 (4.1) 3 (2.0) 7 (5.3) 
% ID at first exam March 2006 31 (21) 15 (10.2 ) 31 (21.5) 13 (9.8) 
No. treatments FR&ID  102 76 23 49 
No. treatments other lameness 8 2 5 1 
Prevalence (95% CI) lame ewes 1.87 
1.39 – 2.55 
0.81 
0.51 – 1.11 
1.69  
1.31 – 2.07 
7.65 
6.65 – 8.65 
Incidence (95% CI) lame ewes  1.33 
0.83-1.83 
0.55 
0.27 – 0.83 
1.06 
0.68 – 1.44 
3.72 
2.88 – 4.56 
Prevalence (95% CI) lame lambs 1.55 
1.09 – 2.01 
0.46 
0.22 – 0.70 
1.03 
0.75 – 1.35 
4.29 
3.59 – 4.99 
Incidence (95% CI) lame lambs  1.01  
0.59 – 1.43 
0.21 
0.07 – 0.35 
0.72 
0.12 – 1.32 
1.84 
0.44 – 2.24 
No. (%) culled 2006  32 (22.0) 36 (24.4) 33 (22.9) 28 (21.2) 
No. (% )FR foot exam Oct.  2006 0 (0) 0 (0) 7 (5) 20 (16) 
No. (% ) ID foot exam Oct. 2006 66 (44) 29 (20) 51 (38) 28 (22) 
 489 
 490 
491 
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Table 3. Number of episodes of lameness by maximum locomotion score in ewes and lambs ; 2005 and 492 
2006 data combined. 493 
 494 
Maximum locomotion 
score
a
 
Intervention ewe 
episodes 
(n=628) 
Control ewe 
episodes 
(n=622) 
Intervention lamb 
episodes 
(n=1047) 
Control lamb 
episodes 
(n=1029) 
2 271 257 306 262 
3 45 85 43 94 
4 46 85 56 89 
5or 6 7 26 5 26 
a
 Kaler et al., 2008b  495 
496 
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Table 4. Number, percent, median and IQ range of weighted lameness score (WLS) for ewes and 497 
lambs in intervention and control groups; 2005 and 2006 data combined 498 
 499 
 Intervention groups combined Control groups combined 
 WLS 0 WLS 1 WLS 2 WLS 0 WLS 1 WLS 2 
Ewes       
Number  
percent 
398 
63 
143 
23 
86 
14 
390 
63 
95 
15 
136 
22 
WLS Median  
WLS IQ range 
0 
– 
6 
4 – 8 
27 
18 – 48 
0 
– 
6 
4 – 9 
63 
29 – 137 
 
Lambs 
 
      
Number  
percent 
754 
72 
217 
21 
76 
7 
755 
73 
142 
14 
132 
13 
WLS Median  
WLS IQ range 
0 
– 
6 
4 – 8 
24 
18 – 40 
0 
– 
6 
4 – 8 
52 
28 – 98 
  500 
501 
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Table 5. Multilevel multinomial logistic regression models of factors associated with weighted 502 
lameness score (WLS) 1 and 2 versus 0 in lactating and dry / pregnant ewes 503 
  WLS 1
 
(n=238) 
 WLS 2 
(n=221) 
 No. (%) 
exposed 
OR 95% CI OR 95% CI 
 
Lactating ewes (n = 1245) 
    
Intervention vs control  626 (50) 1.47 1.10 – 1.96 0.62 0.46 – 0.84 
≥4 yrs vs <4 yrs age 652 (52) 1.17 0.88 – 1.55 1.37 1.02 – 1.84 
 
Random effects 
  
Var. 
 
SE 
 
Var. 
 
SE 
Variation between years   0.05 0.21 0.09 0.22 
Covariance with score      
Ewe  -0.01 0.16   
 
 
Ewes dry / pregnant always 
intervention or control (n = 174) 
 
 
 
WLS 1 
(n=60) 
 
 
WLS 2 
(n=41) 
Intervention vs control  
 
98 (56) 0.63 0.31 – 1.26 0.19 0.08 – 0.43 
Ewe WLS>0 May - Sept 
2005 
79 (45) 1.98 1.00 – 3.93 4.01 1.80 – 8.96 
No. number, % percent, OR: odds ratio, CI, confidence interval, Var.: variance, SE: standard 504 
error  505 
 506 
507 
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Table 6. Multilevel multinomial logistic regression model of factors associated with higher 508 
weighted lameness score (WLS) in lambs in both 2005 and 2006 509 
 No. (%) 
exposed 
WLS1
 
(n=355) 
WLS2
 
(n=207) 
      
Intervention vs control 
group 
1033 (50) 1.54 1.21 – 1.96 0.62 0.45 – 0.84 
Ewe WLS>0 754 (37) 2.49 1.96 – 3.16 3.54 2.60 – 4.80 
Single vs twin 420 (20) 1.45 1.10 – 1.92 1.44 1.02 – 2.05 
Male vs female  1058 (51) 1.28 1.01 – 1.63 1.73 1.28 – 2.36 
 
Random effects 
  
Var. 
 
SE 
 
Var. 
 
SE 
Variance within litters  0.24 0.18 0.44 0.27 
Variance between litters  0.00 0.00 0.00 0.00 
Covariance with score      
Litter  0.40 0.16   
Ewe  0.00 0.00   
No. number, % percent 510 
511 
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Table 7. Multilevel multivariable binomial logistic regression model of factors associated with 512 
ewe body condition ≥ 2.5  513 
At weaning 2005 and 2006      
Variable 
No. (%) 
exposed 
OR 95% CI 
P-
value 
Ewe body condition at previous lambing 
≥2.5 vs <2.5 
880 (77) 2.83 2.09 – 3.83 <0.01 
Rearing single lamb vs twin 390 (34) 1.80 1.38 – 2.36 <0.01 
WLS2 compared with WLS0 or WLS1 
before weaning 
218 (19) 0.54 0.39 – 0.75 <0.01 
Ewe age <4 vs ≥4 yrs 543 (47) 1.59 1.23 – 2.05 <0.01 
Mules vs other crossbreeds 814 (71) 1.52 1.14 – 2.02 <0.01 
Random effects Var. SE   
Variation between years 0.13 0.16   
Lambing 2006 - Ewes always in the intervention or always in control groups (n=167)  
Ewe body condition at weaning 2005 ≥2.5 
vs <2.5  
90 (54) 7.63 3.30 – 17.65 <0.01 
WLS2 between Sept 2005 and Feb 2006 
compared with WLS0 or WLS1 
39 (23) 0.31 0.13 – 0.73 <0.01 
Single vs multiple litter 42 (25) 2.73 1.02 – 7.26 <0.05 
WLS weighted lameness score, No.  number, % percent, OR: odds ratio, CI confidence interval, 514 
Var.: variance, SE: standard error 515 
516 
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Table 8. Performance and cost-benefit analysis of the intervention from weaning 2005
a
 to 517 
weaning 2006 per 100 ewes put to the ram. 518 
Performance 
Intervention 
(No./100 
ewes) 
Control 
(No./100 
ewes) 
Financial results 
Intervention 
(£) 
Control 
(£) 
Empty ewes 4 7 
Slaughter lamb sales 
@ £35 / lamb 
1098 331 
Ewe deaths 3 5 
Store lamb sales
 
@£25 / lamb 
3572 3701 
Productive ewes 93 88 Wool 140 132 
Total lambs born 186 176 Gross receipts 4809 4165 
Lambs born 
dead 
7 10 
Replacement costs 
@£48.50 per ewe 
811 1055 
Lambs born 
alive 
179 166 Total output 3998 3109 
Lambs deaths 
after birth 
5 9 
Feed costs £13.50 / 
ewe 
1201 1136 
Lambs reared 174 157 
Vet & medicine
 
@£5 
/ ewe 
465 440 
Lambs finished 31 10 Intervention cost
 a
 150 0 
Lambs sold as 
stores 
143 148 Other costs £3.80 356 337 
   Total variable costs 2173 1914 
   Gross Margin 1825 1195 
a
 Cost of treatment parenteral antibacterial £1, antibacterial spray £0.30, Time 5.6 min 519 
(unpublished data, The University of Warwick); Minimum wage cost (per hour): £5.05 520 
521 
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Table 9. Cox proportional survival model of time to finishing of lambs. 522 
Among 182 lambs finished before 
140 days of age 
No. (%) 
exposed 
Hazard 
ratio 
95% CI
 a
 
Wald 
χ2 
χ2 P-
value 
In intervention vs control group 162 (89) 2.91 1.92 – 4.42 14.91 <0.01 
Birth weight  ≥ 5.5 vs <5.5kg 121 (66) 1.75 1.24 – 2.47 27.78 <0.01 
Single vs twin lamb 98 (54) 1.44 1.07 – 1.94 30.71 <0.01 
Proportional-hazards assumption 
test based on Schoenfeld residuals 
 χ2= 2.21 P>0.1   
Among 188 lambs finished 
between 140 and 163 days of age  
     
Dam body condition score at 
lambing ≥ 2.5 vs <2.5  
145 (77) 1.69 1.28 – 2.24 11.56 <0.01 
In intervention vs control group 128 (68) 1.48 1.06 – 2.06 16.79 <0.01 
Birth weight  ≥ 5.5 vs <5.5kg 111 (59) 1.41 1.07 – 1.84 22.06 <0.01 
Proportional-hazards assumption 
test based on Schoenfeld residuals 
 χ2= 6.24 P>0.1   
a
 Robust 95% confidence intervals,  No. number, (%) percent 523 
  524 
  525 
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